Dezhan HealthCare Co Ltd (000813.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE000000VV8
Dezhan HealthCare Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 466.49 m CNY | 396.81 m CNY |
| Gross profit | 296.09 m CNY | 222.83 m CNY |
| Operating income | -42.48 m CNY | -173.53 m CNY |
| EBIT | -81.92 m CNY | -418.11 m CNY |
| Net income | -20.41 m CNY | -345.42 m CNY |
| Diluted EPS – continuing operations | -0.01 CNY | -0.16 CNY |
Full history since 1995, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Dezhan HealthCare Co Ltd
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine-atorvastatin calcium tablets, warfarin sodium tablets, trimetazidine hydrochloride tablets, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, hydroxyurea tablets, colchicine tablet, and oseltamivir phosphate capsules. It also involved in the provision of biopeptides, industrial hemp, and medical service business. Dezhan Healthcare Company Limited was founded in 1980 and is based in Beijing, the People's Republic of China.
More stocks
- Shanghai Zhezhong Construction Co Ltd (002346.SZ)
- New Pacific Metals Corp (NUAG.TO)
- HEALTHSTREAM INC (HSTM)
- YIT Oyj (YIT.HE)
- Guangzhou Newlife New Material Co. Ltd. A (301323.SZ)
- Lucky Harvest (002965.SZ)
- Far Eastern Department Stores Ltd (2903.TW)
- HighPeak Energy, Inc. (HPK)
- Boai NKY Pharmaceuticals Ltd (300109.SZ)
- Musashi Seimitsu Industry Co Ltd (7220.T)
- Galliford Try Holdings PLC (GFRD.L)
- Qingdao NovelBeam Technology Co. Ltd. A (688677.SS)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.